C

Care Research Center Inc | Miami, FL

Research site

(Unclaimed)

Location

11760 Bird Road, Suite 511, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

PF-05221304

TAK-503

Allopurinol

Ecopipam Hydrochloride

PF-06865571

Povorcitinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

The main aim of this study is learn more about long-term TAK-503 treatment in children and teenagers with ADHD for whom earlier stimulant treatment d...

Active, not recruiting

Attention Deficit Hyperactivity Disorder

Drug: Guanfacine hydrochloride (TAK-503)

Other: Placebo

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Enrolling

Moderate to Severe Asthma

Drug: ICS-LABA

Other: placebo

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults (D1AMOND)

This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults...

Enrolling

Tourette Disorder

Drug: Ecopipam Hydrochloride

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients (EURELIA2)

The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the effi...

Enrolling

Hyperuricemia

Tophi

Drug: Tigulixostat

Drug: Placebo